# A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis

> **NCT03727451** · PHASE2 · COMPLETED · sponsor: **Bellerophon** · enrollment: 17 (actual)

## Conditions studied

- Pulmonary Hypertension
- Pulmonary Fibrosis
- Sarcoidosis, Pulmonary

## Interventions

- **COMBINATION_PRODUCT:** iNO

## Key facts

- **NCT ID:** NCT03727451
- **Lead sponsor:** Bellerophon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-30
- **Primary completion:** 2021-09-07
- **Final completion:** 2022-06-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727451, "A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03727451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*